Medicare ACO Information

 
ACO name and location

Health Connect Partners, LLC
1801 SW Lind Avenue
Morin Building, 1st Floor
Renton, WA, 98057

ACO primary contact

Dominique Buhl
253-881-5949
Dominique.Buhl@providence.org

Organizational Information

ACO participants

ACO Participants

ACO Participant in Joint Venture
Pet/Ct Imaging At Swedish Cancer Institute LLC
Y
Swedish Edmonds
N
Providence Health & Services- Washington

N

PROVIDENCE HEALTH & SERVICES WASHINGTON
N
Providence Health Serviceswa
N
St. Joseph Heritage Healthcare
N
PROVIDENCE HEALTH & SERVICES – WASHINGTON
N
Providence Health Services Wa
N
PROVIDENCE HEALTH & SERVICES – WA
N
PACMED CLINICS
N
Providence St. Joseph Medical Center
N
Swedish Health Services
N
Facey Medical Foundation
N

ACO governing body

Member Last Name
Member First Name
Member Title/Position
Member's Voting Power
Membership Type
ACO Participant TIN Legal Business Name/DBA, if Applicable
Sadagopan
Deepak
ACO Chief Executive Officer
1
Other: ACO Chief Executive Officer
Providence Health & Services - Washington
Weidig
David
ACO Chief Medical Officer
1
Other: Chief Medical Officer
Providence Health & Services – Washington
Meadows
Richard
CMO Ambulatory - Kadlec
0
Other: Medical Officer
Kadlec Regional Medical Center
Martin
James
Medical Director and Associate CMO
1
ACO Participant Representative
Swedish
Brown
Tamara
Chief Financial Officer
1
ACO Participant Representative
Providence Health & Services – Alaska
Rafeh
Zach
Chief Medical Officer SW PMG, PPN Administration
1
ACO Participant Representative
Providence Health & Services – Washington
Davidson
Timothy
Chief Executive Physician
1
ACO Participant Representative
Providence Health & Services – Washington
Mokrohisky
Christy
VP Population Health Management St. Joseph Heritage Health
1
ACO Participant Representative
St. Joseph Heritage Health
Ferguson
Monica
Physician
1
ACO Participant Representative
St. Joseph Heritage Health
Rogers
Terry
Medicare Beneficiary Representative, CEO for the Foundation for Health Care Quality
1
Medicare Beneficiary Representative
Medicare Beneficiary Representative
Ivanjack
Lisa
Chief Medical Officer
PacMed
1
ACO Participant Representative
Pacific Medical Centers
Campbell
Stephen
Chief Medical Officer, Northwest Region
1
ACO Participant Representative
Providence Health & Services – Washington
Marshall
Michael
Chief Physician Executive
1
ACO Participant Representative
Providence Health & Services – Washington
Shelton
Laura
Physician Leader-Montana region
1
ACO Participant Representative
Providence Health & Services – Montana
Wakai
Mark
Chief Population Health Officer WA/MT region
0
Other: Medical Officer
Providence Health & Services – WA/Montana

Key ACO clinical and administrative leadership

ACO Executive: Deepak Sadagopan
Medical Director: David Weidig
Compliance Officer: Amy Riedel
Quality Assurance/Improvement Officer: Angie Beck

Associated committees and committee leadership

Committee Name
Committee Leader Name and Position
Operations, Analytics & Compliance Committee
Deepak Sadagopan – Chair
Governing Body Compliance Committee
Deepak Sadagopan – Chair

Types of ACO participants, or combinations of participants, that formed the ACO

  • ACO professionals in a group practice arrangement
  • Hospital employing ACO professionals
  • Partnerships or joint venture arrangements between hospitals and ACO professionals

Shared Savings and Losses

Amount of shared savings/losses

  • Third Agreement Period
    • Performance Year 2020, $26,113,601
  • Second Agreement Period
    • Performance Year 2019, $14,116,371
    • Performance Year 2018, $0
    • Performance Year 2017, $10,747,306
  • First Agreement Period
    • Performance Year 2016, $0
    • Performance Year 2015, $0
    • Performance Year 2014, $0

Shared savings distribution

Third Agreement Period

  • Performance Year 2020
    • Proportion invested in infrastructure: 0%
    • Proportion invested in redesigned care processes/resources: 0%
    • Proportion of distribution to ACO participants: 100%

Second Agreement Period

  • Performance Year 2020
    • Proportion invested in infrastructure: 0%
    • Proportion invested in redesigned care processes/resources: 0%
    • Proportion of distribution to ACO participants: 100%
  • Performance Year 2019
    • Proportion invested in infrastructure: 0% 
    • Proportion invested in redesigned care processes/resources: 0% 
    • Proportion of distribution to ACO participants: 100% 
  • Performance Year 2018
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
  • Performance Year 2017
    • Proportion invested in infrastructure: 0%
    • Proportion invested in redesigned care processes/resources: 0%
    • Proportion of distribution to ACO participants: 100%

First Agreement Period

  • Performance Year 2016
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
  • Performance Year 2015
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
  • Performance Year 2014
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A

Quality Performance Results

2020 quality performance results

ACO Quality Measure Number

Measure Name

Rate

ACO Mean

ACO-43
Ambulatory Sensitive Condition Acute Composite (AHRQ Prevention Quality Indicator (PQI) #91)
0.51
0.95
ACO-13
Falls: Screening for Future Fall Risk
62.40
84.97
ACO-14
Preventive Care and Screening: Influenza Immunization
66.26
76.03
ACO-17
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
63.64
81.67
ACO-18
Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan
62.37
71.46
ACO-19
Colorectal Cancer Screening
75.86
72.59
ACO-20
Breast Cancer Screening
78.18
74.05
ACO-42
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
84.91
83.37
ACO-27
Diabetes Mellitus: Hemoglobin A1c Poor Control
13.77
14.70
ACO-28
Hypertension (HTN): Controlling High Blood Pressure
66.55
72.87

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020 through the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized, All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for-reporting, given the impact of the coronavirus disease 2019 (COVID-19) public health emergency (PHE) on these measures.

 For previous years’ financial and quality performance results, please visit data.cms.gov.

Payment Rule Waivers

  • Skilled Nursing Facility (SNF) 3-day Rule Waiver:
    • Our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR § 425.612. 
  • Waiver for Payment for Telehealth Services:
    •  Our ACO clinicians provide telehealth services using the flexibilities under 42 CFR § 425.612(f) and 42 CFR § 425.613.